These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8411785

  • 1. Time course of dopamine-D2 and serotonin-5-HT2 receptor occupancy rates by haloperidol and clozapine in vivo.
    Sumiyoshi T, Kido H, Sakamoto H, Urasaki K, Suzuki K, Yamaguchi N, Mori H, Shiba K, Yokogawa K, Ichimura F.
    Jpn J Psychiatry Neurol; 1993 Mar; 47(1):131-7. PubMed ID: 8411785
    [Abstract] [Full Text] [Related]

  • 2. Time course of dopamine1,2 and serotonin2 receptor binding of antipsychotics in vivo.
    Sumiyoshi T, Kido H, Sakamoto H, Urasaki K, Suzuki K, Yamaguchi N, Mori H, Shiba K.
    Pharmacol Biochem Behav; 1994 Sep; 49(1):165-9. PubMed ID: 7816868
    [Abstract] [Full Text] [Related]

  • 3. In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol.
    Sumiyoshi T, Kido H, Sakamoto H, Urasaki K, Suzuki K, Yamaguchi N, Mori H, Shiba K, Yokogawa K.
    Pharmacol Biochem Behav; 1994 Mar; 47(3):553-7. PubMed ID: 7516078
    [Abstract] [Full Text] [Related]

  • 4. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA, Szczepanik AM.
    Brain Res; 1989 May 22; 487(2):288-98. PubMed ID: 2525063
    [Abstract] [Full Text] [Related]

  • 5. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
    Natesan S, Reckless GE, Barlow KB, Nobrega JN, Kapur S.
    Schizophr Res; 2008 Oct 22; 105(1-3):224-35. PubMed ID: 18710798
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S, Zipursky RB, Remington G.
    Am J Psychiatry; 1999 Feb 22; 156(2):286-93. PubMed ID: 9989565
    [Abstract] [Full Text] [Related]

  • 9. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.
    Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS, De Loore K, Leysen JE.
    Psychopharmacology (Berl); 1996 Mar 22; 124(1-2):57-73. PubMed ID: 8935801
    [Abstract] [Full Text] [Related]

  • 10. Atypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancy.
    Sumiyoshi T, Suzuki K, Sakamoto H, Yamaguchi N, Mori H, Shiba K, Yokogawa K.
    Neuropsychopharmacology; 1995 Feb 22; 12(1):57-64. PubMed ID: 7766287
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G.
    J Pharmacol Exp Ther; 1998 Sep 22; 286(3):1341-55. PubMed ID: 9732398
    [Abstract] [Full Text] [Related]

  • 14. [A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain].
    Matsubara R.
    Hokkaido Igaku Zasshi; 1993 Jul 22; 68(4):570-82. PubMed ID: 7687976
    [Abstract] [Full Text] [Related]

  • 15. Binding of [3H]haloperidol to dopamine D2 receptors in the rat striatum.
    Tsuchihashi H, Sasaki T, Kojima S, Nagatomo T.
    J Pharm Pharmacol; 1992 Nov 22; 44(11):911-4. PubMed ID: 1361536
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain.
    O'Dell SJ, La Hoste GJ, Widmark CB, Shapiro RM, Potkin SG, Marshall JF.
    Synapse; 1990 Nov 22; 6(2):146-53. PubMed ID: 2237777
    [Abstract] [Full Text] [Related]

  • 20. Effects of ritanserin on haloperidol-induced dopamine (D2) receptor up-regulation in the rat.
    Szczepanik AM, Wilmot CA.
    Neurosci Lett; 1997 Aug 08; 231(2):91-4. PubMed ID: 9291148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.